Canada’s cannabis extraction market is led by a small group of GMP-certified processors responsible for much of the country’s vape oils, distillates, and edible inputs. These companies sit behind the products lining dispensary shelves, but their role is rarely visible to consumers. How they operate, what they specialize in, and where they invest helps explain who leads the sector today and why it matters.
Why This Matters Now
- Extracts are a major part of legal cannabis sales: Vapes, oils, and concentrates now account for roughly one-quarter to one-third of retail sales, depending on province and product mix.
- Exports remain possible, but only for a narrow group: International shipments continue mainly for EU-GMP and pharma-grade producers, with medical markets setting the pace.
- Regulatory pressure keeps increasing: Health Canada’s tracking, testing, and reporting rules place more responsibility on processors than in earlier years.
- The market is thinning out: Closures, licence surrenders, and takeovers picked up through 2024 and into 2025 as inventories stayed high and pricing tightened.
Cannabis and Casinos: How Canada Became a Leader in Both
Canada’s global reputation for innovation and quality extends beyond cannabis extraction to the world of online casinos. With provinces like Ontario legalizing and regulating online gambling, Canadians now have access to safe, well-regulated platforms offering diverse casino games.
Those looking for the best online casinos Canada has on offer can browse proven options that offer secure transactions and exciting experiences. These platforms feature detailed reviews, payment methods, and bonus comparisons, helping players make informed choices. Whether you prefer classic games or live dealer options, the site provides insights into the most trusted places to play. This mirrors the cannabis industry, where strict standards ensure high-quality products for consumers. Just as Canadian cannabis extracts are sought after internationally, the country’s gaming platforms are gaining recognition for their responsible approach and user experience.
As the market grows, fresh picks are drawing attention with new features and exclusive deals. Players interested in what’s new in the market can find emerging platforms bringing creative twists to the experience. This page highlights recently launched sites, their unique bonuses, and the latest game selections, making it easy to keep up with industry trends. It also offers guidance on how to spot secure and fair platforms, ensuring a safe and enjoyable experience.
Just like online casinos offer exciting gaming experiences, cannabis companies are using innovation to deliver top-notch products. Now, let’s dive into reviews of the top cannabis extraction companies to see what makes them leaders in their field.
MediPharm Labs
Key Info | Details |
|---|---|
Location | Barrie, Ontario |
Size | 70,000 sq ft |
Certifications | GMP, DEL, Cannabis Drug License |
Extraction | Supercritical CO2 |
Processing Capacity | Industrial scale |
Special Feature | Clinical trial capabilities |
MediPharm Labs operates a 70,000 sq ft GMP-certified facility in Barrie, featuring pharmaceutical-grade equipment. Their extraction process includes supercritical CO2, winterization, and wiped-film distillation, yielding 80-95% pure cannabinoids. They’ve partnered with McMaster University for clinical trials and hold Canada’s first Drug Establishment License. Recent focus includes CBN production and pharmaceutical-grade isolates. Export capabilities span multiple continents, backed by EU-GMP certification.
Hempsana (Closed)
Key Info | Details |
|---|---|
Status | Bankruptcy March 2024 |
Location | Ontario |
Type | EU-GMP facility |
Products | CBD, CBG, CBN extracts |
Focus | Wholesale, white label |
Issue | Liquidity constraints |
Hempsana was once a notable player in Canada’s cannabis extraction industry, offering high-quality products like full spectrum resin, distillate, and cannabinoid isolates. Operating from an EU-GMP-certified facility in Ontario, they specialized in producing crude resin (65-75% concentration) and distillate high (80%+ purity) for wholesale and white-label markets. They also focused on combining distillate and terpenes for tailored product formulations.
Despite their expertise in creating some of the purest THC extracts and their advanced ethanol extraction methods, Hempsana faced liquidity issues, leading to bankruptcy in March 2024. Limited operations continue under restructuring, with remaining Hempsana stock available for sale. Their service platform, which included white-label and contract manufacturing, set a high standard but also highlighted challenges in an evolving industry.
Motif Labs
Key Info | Details |
|---|---|
Location | London, Ontario |
Size | 75,000 sq ft |
Parent | Organigram |
Extraction | CO2, Hydrocarbon |
Monthly Capacity | 2-3M units |
Investment | $1.5M in new facility |
Motif Labs has invested $1.5M in their new 75,000 sq ft facility, enabling 2-3M units monthly production. Their expanded hydrocarbon extraction capacity (4x increase) supports diverse product lines. The facility includes three truck-level docks, automated pre-roll lines, and dedicated extraction rooms. As an Organigram subsidiary, they’ve accessed additional capital for rapid expansion. Current focus includes high-volume vape production and specialized pre-roll manufacturing.
Indiva
Key Info | Details |
|---|---|
Location | London, Ontario |
Products | Edibles, chocolates, soft chews |
Market Position | #1 in edibles |
Brands | Bhang, Pearls, No Future |
Facility | Modern kitchen |
Focus | Product innovation |
Indiva leads Canada’s edibles market from their London facility. Their product line includes Bhang chocolates (made with premium cacao), Pearls gummies (featuring CBG/CBN options), and precisely-dosed Blips tablets. They use Callebaut chocolate for the 1432 line and offer various cannabinoid ratios. Recent launches include innovative edibles targeting specific consumer segments. Distribution covers all major Canadian markets.
Decibel Cannabis
Key Info | Details |
|---|---|
HQ | Calgary |
Processing | 15,000 sq ft |
Capacity | 65,000kg annually |
Recent Move | AgMedica acquisition |
Brands | Qwest, General Admission |
Build | EU GMP specs |
Decibel operates a 15,000 sq ft processing facility with 65,000 kg annual capacity. Their three-site cultivation network includes the premium Qwest Estate. The AgMedica acquisition adds EU-GMP capabilities and global market access. The product range spans premium craft cannabis (Qwest) to mainstream offerings (General Admission). The processing facility features CO2 extraction and advanced formulation capabilities.
Comparing the Giants: Who Does What Best?
Category | Top Performer | Why They Lead |
|---|---|---|
Taste and Experience | Indiva | Known for their flavorful edibles like Bhang Chocolate and Pearls by Grön. |
Pharma-Grade Products | MediPharm Labs | DEL-certified, with partnerships in clinical trials and pharmaceutical research. |
Craft Cannabis | Decibel Cannabis | Qwest brand is legendary for small-batch luxury cannabis. |
Innovation and Scale | Motif Labs | Advanced facilities and 4X increase in hydrocarbon extraction capacity. |
Legacy | Hempsana (Closed) | Set a high standard for quality despite financial struggles. |
Numbers Behind Canada’s Cannabis Extraction Industry
- Canada’s legal cannabis market reached about $5.2 billion CAD in 2024, based on national retail data.
- Cannabis extracts generated about $1.7 billion CAD in annual sales, combining inhaled and ingested products.
- Consumer use continues to shift toward processed formats, with edibles leading medical sales and extracts holding about 25% of adult-use sales by unit share in early 2025.
- In Q1 2025, dried flower fell below 50% market share, while edibles reached 26% and extracts held about 25% of adult-use sales by unit share.
- Cannabis extracts show an inventory-to-sales ratio of roughly 4.4 to 1, higher than dried cannabis, adding pressure on pricing and processing margins.
- EU-GMP status remains a practical requirement for exports, allowing firms such as MediPharm Labs and Decibel to supply regulated medical channels abroad where permitted.
Editorial note
This article is based on publicly available data, regulatory filings, and industry reporting through 2024 and 2025. Company descriptions reflect operations at the time of writing and may change. This content is for informational purposes only and does not constitute investment, medical, or legal advice.